» Articles » PMID: 15192093

Identification of Domain Structures in the Propeptide of Corin Essential for the Processing of Proatrial Natriuretic Peptide

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Jun 12
PMID 15192093
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Corin is a type II transmembrane serine protease and functions as the proatrial natriuretic peptide (pro-ANP) convertase in the heart. In the extracellular region of corin, there are two frizzled-like cysteine-rich domains, eight low density lipoprotein receptor (LDLR) repeats, a macrophage scavenger receptor-like domain, and a trypsin-like protease domain at the C terminus. To examine the functional importance of the domain structures in the propeptide of corin for pro-ANP processing, we constructed a soluble corin, EKshortCorin, that consists of only the protease domain and contains an enterokinase (EK) recognition sequence at the conserved activation cleavage site. After being activated by EK, EKshortCorin exhibited catalytic activity toward chromogenic substrates but failed to cleave pro-ANP, indicating that certain domain structures in the propeptide are required for pro-ANP processing. We then constructed a series of corin deletion mutants and studied their functions in pro-ANP processing. Compared with that of the full-length corin, a corin mutant lacking frizzled 1 domain exhibited approximately 40% activity, whereas corin mutants lacking single LDLR repeat 1, 2, 3, or 4 had approximately 49, approximately 12, approximately 53, and approximately 77% activity, respectively. We also made corin mutants with a single mutation at a conserved Asp residue that coordinates Ca(2+)-binding in LDLR repeats 1, 2, 3, or 4 (D300Y, D336Y, D373Y, and D410Y) and showed that these mutants had approximately 25, approximately 11, approximately 16, and approximately 82% pro-ANP processing activity, respectively. Our results indicate that frizzled 1 domain and LDLR repeats 1-4 are important structural elements for corin to recognize its physiological substrate, pro-ANP.

Citing Articles

Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia.

Binder N, Beard S, de Alwis N, Fato B, Nguyen T, Kaituu-Lino T Int J Mol Sci. 2023; 24(7).

PMID: 37047162 PMC: 10094118. DOI: 10.3390/ijms24076182.


Edema formation in congestive heart failure and the underlying mechanisms.

Abassi Z, Khoury E, Karram T, Aronson D Front Cardiovasc Med. 2022; 9:933215.

PMID: 36237903 PMC: 9553007. DOI: 10.3389/fcvm.2022.933215.


B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?.

Nishikimi T, Nakagawa Y Biology (Basel). 2022; 11(7).

PMID: 36101415 PMC: 9312360. DOI: 10.3390/biology11071034.


Corin Missense Variants, Blood Pressure, and Hypertension in 11 322 Black Individuals: Insights From REGARDS and the Jackson Heart Study.

Parcha V, Irvin M, Lange L, Armstrong N, Pampana A, Meyer M J Am Heart Assoc. 2022; 11(12):e025582.

PMID: 35699180 PMC: 9238660. DOI: 10.1161/JAHA.121.025582.


Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling.

Giovannini D, Andreola F, Spitalieri P, Krasnowska E, Colini Baldeschi A, Rossi S Cell Death Discov. 2021; 7(1):330.

PMID: 34725335 PMC: 8560781. DOI: 10.1038/s41420-021-00723-6.